Profit Knows No Borders, Selling Gardasil to the Rest of the World: Part Four of the Politics and PR of Cervical Cancer
Tagged :
Print 
Text Size: Normal / Medium / Large
Printer-friendly versionBy Judith Siers Poisson
The three previous articles in this series have examined the Politics and PR of Cervical Cancer in the United States. This fourth and final installment will look at how Merck's so-called "cervical cancer vaccine," Gardasil, is being marketed in Canada, Australia, and New Zealand.
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.